Headquartered in Copenhagen, with a presence in San Francisco, Boston and Singapore, Novo Holdings is a world-leading life science investor with a focus on creating long-term value
Our purpose is to be a supportive owner of the Novo Group companies and to enable and make a positive and growing impact on health, science and society by generating attractive long-term returns on the assets of the Novo Nordisk Foundation
We are the holding company of the Novo Group and manage the wealth of the Novo Nordisk Foundation. We invest in life science companies at all stages of development and in a broad portfolio of equity and fixed income securities, as well as real assets (real estate and infrastructure). For more information, download our fact sheet.
Novo Holdings employs investment and business professionals focused on delivering attractive returns for the benefit of the Novo Nordisk Foundation.
We aspire to become catalysts of change by investing in companies that – like Novo Holdings – believe that there are achievable solutions to the pressing challenges facing both humankind and our planet. Read more.
Total investment assets of Novo Holdings at the end of 2021.
Return on Life Science investments last 5 years.
Return on Capital investments last 5 years.
Novo Holdings A/S
Tuborg Havnevej 19
2900 Hellerup
Denmark
+45 3527 6500
CVR# 24257630
Novo Ventures (US) Inc.*
200 Clarendon Street, Floor 45
Boston, MA 02116
USA
Novo Ventures (US) Inc.*
501 2nd Street, Suite 300
San Francisco, CA 94107
USA
+1 (415) 552-6686
Novo Holdings Equity Asia Pte. Ltd.*
6 Battery Road #23-03
Singapore 049909
Singapore
Novo Holdings Equity US Inc.*
501 2nd Street, Suite 300
San Francisco, CA 94107
USA
+1 (415) 552-6686
Novo Holdings Equity US Inc.*
200 Clarendon Street, Floor 45
Boston, MA 02116
USA
Media Relations
Christian Mostrup Scheel
Senior Press Officer
cims@novo.dk
+45 3067 4805
*Novo Ventures (US) Inc., Novo Holdings Equity US Inc., comprising Novo Growth and Principal Investments, and Novo Holdings Equity Asia Pte. Ltd. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.